Leadership

Voyager’s leaders bring deep expertise in biopharmaceutical development, neurotherapeutics, genetic medicines, strategic management, and organizational culture. The result is a company delivering on its breakthroughs.

Management Team

Alfred Sandrock, M.D., Ph.D.

Alfred Sandrock, M.D., Ph.D.

President and Chief Executive Officer

Todd Carter, Ph.D.

Todd Carter, Ph.D.

Chief Scientific Officer

Jacquelyn Fahey Sandell

Jacquelyn Fahey Sandell

Chief Legal Officer

Trista Morrison

Trista Morrison

Chief Corporate Affairs Officer and Chief of Staff to the CEO

Peter Pfreundschuh

Peter Pfreundschuh

Chief Financial Officer

Michelle Quinn Smith

Michelle Quinn Smith

Chief Human Resources Officer

Robin Swartz

Robin Swartz

Chief Operating Officer, Acting Chief Business Officer

Board of Directors

Michael Higgins

Michael Higgins

Chair

Grace E. Colón, Ph.D.

Grace E. Colón, Ph.D.

James Geraghty

James Geraghty

Steven Hyman, M.D

Steven Hyman, M.D

Catherine J. Mackey, Ph.D.

Catherine J. Mackey, Ph.D.

Jude Onyia, Ph.D.

Jude Onyia, Ph.D.

Glenn Pierce, M.D., Ph.D.

Glenn Pierce, M.D., Ph.D.

Alfred Sandrock, M.D., Ph.D.

Alfred Sandrock, M.D., Ph.D.

George Scangos, Ph.D.

George Scangos, Ph.D.

Nancy Vitale

Nancy Vitale

Scientific Advisory Board

Guangping Gao, Ph.D.

Director, University of Massachusetts Medical School (UMMS) Gene Therapy Center & Vector Core; Scientific Director, UMMS-China Program Office; Professor of Molecular Genetics and Microbiology, UMMS.

Dinah Sah, Ph.D.

Former Chief Scientific Officer of Voyager and former Vice President of Research at Alnylam Pharmaceuticals.

Phillip Zamore, Ph.D.

Howard Hughes Medical Institute Investigator; Gretchen Stone Cook Chair of Biomedical Sciences, Professor of Biochemistry and Molecular Pharmacology, and Chair of the RNA Therapeutics Institute, University of Massachusetts Medical School.